Abstract
Pamidronate, alendronate, APHBP and neridronate are a group of drugs, known as second-generation bisphosphonates (2G-BPs), commonly used in the treatment of bone-resorption disorders, and recently their use has been related to some collateral side effects. The therapeutic activity of 2G-BPs is related to the inhibition of the human Farnesyl Pyrophosphate Synthase (hFPPS). Available inhibitory activity values show that 2G-BPs act time-dependently, showing big differences in their initial inhibitory activities but similar final IC50 values. However, there is a lack of information explaining this similar final inhibitory potency. Although different residues have been identified in the stabilization of the R2 side chain of 2G-BPs into the active site, similar free binding energies were obtained that highlighted a similar stability of the ternary complexes, which in turns justified the similar IC50 values reported. Free binding energy calculations also demonstrated that the union of 2G-BPs to the active site were 38 to 54 kcal mol−1 energetically more favourable than the union of the natural substrate, which is the basis of the inhibition potency of the hFPPS activity.
Similar content being viewed by others
References
Giger EV, Castagner B, Leroux JC (2013) J Control Release 167:175–188
Li B, Chau JFL, Wang X, Leong WF (2011) J Cell Biochem 112:1229–1242
Russell RGG, Rogers MJ, Frith JC, Luckman SP, Coxon FP, Benford HL, Croucher PI, Shipman C, Fleish HA (1999) J Bone Miner Res 14:53–65
Frith JC, Mönkkönen J, Auriola S, Mönkkönen H, Rogers MJ (2001) Arthritits Rheum 44:2201–2210
Frith JC, Mönkkönen J, Blackburn M, Russell RGG, Rogers MJ (1997) J Bone Miner Res 12:1358–1367
Rogers MJ, Gordon S, Benford HL, Coxon FP, Luckman SP, Monkkonen J, Frith JC (2000) Cancer 88:2961–2978
Schenk R, Eggli P., Fleisch H, Rosini S (1986) Calcif Tissue Int 38:349–349
Muhlbauer RC, Bauss F, Schenk R, Janner M, Bosies E, Strein K, Fleisch H (1991) J Bone Miner Res 6:1003–1011
U.S. Food and Drug Administration (2015) FDA approved drug products. Retrived from http://www.accessdata.fda.gov/scripts/cder/drugsatfda/index.cfm
European Medicines Agency, EMA (2015) European public assessment reports. Retrived from http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/landing/epar_search.jsp&mid=WC0b01ac058001d124
Gatti D, Rossini M, Viapiana O, Idolazzi L, Adami S (2013) Ther Clin Risk Manag 9:139–147
O’Rourke NP, McCloskey EV, Rosini S, Coleman RE, Kanis JA (1994) Br J Cancer 69:914–917
Jang SW, Lee JW, Ryu DS, Son M, Kang MJ (2014) Int J Biol Macromol 70:174–178
Jeal W, Barradell LB, Mctavish D (1997) Drugs 53(3):415–434
Ott SM (2012) Kidney Int 82:833–835
CADIME (2010) Boletín Terapéutico Andaluz 26(2):1–4
Loke YK, Jeevanantham V, Singh S (2009) Drug Saf 32(3):219–228
Majumdar SR (2008) BMJ 336(7648):784–785
Fraunfelder FW, Fraunfelder FT (2004) Ophthalmology 111(7):1275–1279
Hess LM, Jeter JM, Benham-Hutchins M, Alberts DS (2008) Am J Med 121:475–483
Bauss F, Pfister T, Papapoulos S (2008) J Bone Miner Metab 26:406–408
Ruggiero SL, Mehrotra B (2009) Annu Rev Med 60:85–96
Whitaker M, Guo J, Kehoe T, Benson G (2012) N Engl J Med 366:2048–2051
Park-Wyllie LP, Mamdani MM, Juurlink DN, Hawker GA, Gunraj N, Austin PC, Whelan DB, Weiler JP, Laupacis A (2011) J Am Med Assoc 305:783–789
Papapoulos SE, E.M.W. Eekhoff, Zwinderman AH (2006) J Bone Miner Res 21:88–91
Koyama T, Saito A, Ogura K, Seto S (1980) J Am Chem Soc 102:3614–3618
Luckman SP, Coxon FP, Ebetino FH, Russell RG, Rogers MJ (1998) J Bone Miner Res 13:1668–1678
Fisher JE, Rogers MJ, Halasy JM, Luckman SP, Hughes DE, Masarachia PJ, Wesolowski G, Russell RG, Rodan GA, Reszka AA (1999) Proc Natl Acad Sci USA 96:133–138
Sinensky M (2000) Biochim Biophys Acta 1484:93–106
Zhang FL, Casey PJ (1996) Annu Rev Biochem 65:241–269
Zhang Y, Cao R, Yin F, Hudock MP, Guo R-T, Krysiak K, Mukherjee S, Gao Y-G, Robinson J, Song Y, No JH, Bergan K, Leon A, Cass L, Goddard A, Chang T-K, Lin F-Y, Van Beek E, Papapoulos S, Wang AH-J, Kubo T, Ochi M, Mukkamala D, Oldfield E (2009) J Am Chem Soc, 131:5153–5162
Kavanagh KL, Guo K, Dunford JE, Wu X, Knapp S, Ebetino FH, Rogers MJ, Russell RG, Opperman U (2006) Proc Natl Acad Sci USA 103:7829–7834
Rondeau JM, Bitsch F, Bourgier E, Geiser M, Hemmig R, Kroemer M, Lehmann S, Ramage P, Rieffel S, Strauss A, Green JR, Jahnke W (2006) Chem Med Chem 1:267–273
Park J, Lin Y-S, Tsantrizos Y-S, Berghuis AM (2014) Acta Cryst 70:299–304
Fernández D, Ortega-Castro J, Mariño L, Perelló J, Frau J (2015) J Comput Aided Mol Des 29:667–680
Ohno K, Mori K, Orita M, Takeuchi M (2011) Curr Med Chem 18:220–233
Fraser J, Glickman FJ, Schmid A (2007) Assay Drug Dev Technol 5:205–214
Poulter CD, Rilling HC (1978) Acc Chem Res 11:307–313
Holloway PW, Popjak G (1967) Biochem J, 104:57–70
Martin MB, Arnold W, Heath HT, Urbina JA, Oldfield E (1999) Biochem Biophys Res Commun 263:754–758
Park J, Lin Y-S, De Schutter JW, Tsantrizos YS, Berghuis AM (2012) BMC Struct Biol 12:32
Dunford JE, Kwaasi AA, Rogers MJ, Barnett BL, Ebetino FH, Russell RGG, Oppermann U, Kavanagh KL (2008) J Med Chem, 51:2187–2195
Fernández D, Ortega-Castro J, Frau J (2013) J Comput Aided Mol Des 27:739–754
Gabelli SB, McLellan JS, Montalvetti A, Oldfield E, Docampo R, Amzel LM (2006) Proteins 62:80–88
Tsoumpra MK, Muniz JR, Barnett BL, Kwaasi AA, Pilka ES, Kavanagh KL, Evdokimov A, Walter RL, Delft FV, Ebetino FH, Oppermann U, R.G.G. Russell, Dunford JE (2015) Bone 81:478–486
N.N.F.S.A. Cerqueira, Ribeiro J, Fernandes PA, Ramos MJ (2011) Int J Quantum Chem, 111:1208–1212
Humphrey W, Dalke A, Schulten K (1996) J Molec Graphics 14:33–38
Morris GM, Goodsell DS, Halliday RS, Huey R, Hart WE, Belew RK, Olson AJ (1998) J Comput Chem 19:1639–1662
Reed AE, Weinstock RB, Weinhold F (1985) J Chem Phys 83:735–746
Reed AE, Curtiss LA, Weinhold F (1988) Chem Rev, 88:899–926
Case DA, Darden TA, Cheatham TE III, Simmerling CL, Wang J, Duke RE, Luo R, Walker RC, Zhang W, Merz KM, Roberts B, Hayik S, Roitberg A, Seabra G, Swails J, Götz AW, Kolossváry I, Wong KF, Paesani F, Vanicek J, Wolf RM, Liu J, Wu X, Brozell SR, Steinbrecher T, Gohlke H, Cai Q, Ye X, Wang J, Hsieh MJ, Cui G, Roe DR, Mathews DH, Seetin MG, Salomon-Ferrer R, Sagui C, Babin V, Luchko T, Gusarov S, Kovalenko A, Kollman PA (2012) AMBER 12. University of California, San Francisco
Duan Y, Wu C, Chowdhury S, Lee MC, Xiong G, Zhang W, Yang R, Cieplak P, Luo R, Lee T (2003) J Comput Chem 24:1999–2012
Lee MC, Duan Y (2004) Proteins 55:620–634
Wang J, Wolf RM, Caldwell JW, Kollman PA, Case DA (2004) J Comput Chem, 25:1157–1174
Meagher KL, Redman LT, Carlson HA (2003) J Comp Chem, 24:1016–1025
Frisch MJ, Trucks GW, Schlegel HB, Scuseria GE, Robb MA, Cheeseman JR, Montgomery JA Jr, Vreven T, Kudin KN, Burant JC, Millam JM, Iyengar SS, Tomasi J, Barone V, Mennucci B, Cossi M, Scalmani G, Rega N, Petersson GA, Nakatsuji H, Hada M, Ehara M, Toyota K, Fukuda R, Hasegawa J, Ishida M, Nakajima T, Honda Y, Kitao O, Nakai H, Klene M, Li X, Knox JE, Hratchian HP, Cross JB, Bakken V, Adamo C, Jaramillo J, Gomperts R, Stratmann RE, Yazyev O, Austin AJ, Cammi R, Pomelli C, Ochterski JW, Ayala PY, Morokuma K, Voth GA, Salvador P, Dannenberg JJ, Zakrzewski VG, Dapprich S, Daniels AD, Strain MC, Farkas O, Malick DK, Rabuck AD, Raghavachari K, Foresman JB, Ortiz JV, Cui Q, Baboul AG, Clifford S, Cioslowski J, Stefanov BB, Liu G, Liashenko A, Piskorz P, Komaromi I, Martin RL, Fox DJ, Keith T, Al-Laham MA, Peng CY, Nanayakkara A, Challacombe M, Gill PMW, Johnson B, Chen W, Wong MW, Gonzalez C, Pople JA (2004) Gaussian 03, Revision C.02 Gaussian Inc., Wallingford CT
Jorgensen WL, Chandrasekhar J, Madura JD, Impey RW, Klein ML (1983) J Chem Phys 79:926–935
Bekker H, Berendsen HJC, Dijkstra EJ, Achterop S, van Drunen R, van der Spoel D, Sijbers A, Keegstra H, Reitsma B, M.K.R. Renardus (1993) In: de Groot RA, Nadrchal J Physics computing 92, World Scientific Publishing, Singapore
Berendsen HJC, van der Spoel D, van Drunen R (1995) Comp Phys Commun 91:43–56
Lindahl E, Hess B, van der Spoel D (2001) J Mol Model 7:306–317
van der Spoel D, Lindahl E, Hess B, Groenhof G, Mark AE, Berendsen HJC (2005) J Comp Chem 26:1701–1718
Hess B, Kutzner C, van der Spoel D, Lindahl E (2008) J Chem Theory Comp 4:435–447
Darden T, York D, Pedersen L (1993) J Chem Phys 98:10089–10092
B. Hess B (2008) J Chem Theory Comput 4:116–122
Berendsen HJC, Postma JPM, Vangunsteren WF, Dinola A, Haak JR (1984) J Chem Phys, 81:3684–3690
Parrinello M, Rahman A (1981) J Appl Phys, 52:7182–7190
Pohorille A, Jarzynski C, Chipot C (2010) J Phys Chem B 114:10235–10253
Bennett CH (1976) J Comput Phys 22:245–268
Dixit SB, Chipot C (2001) J Phys Chem A 105:9795–9799
Haynes WM CRC Handbook of Chemistry and Physics, 93rd edn. Taylor & Francis Group, Abingdon
Johnson ER, Keinan S, Mori-Sanchez P, Contreras-Garcia J, Cohen AJ, Yang W (2010) J Am Chem Soc 132:6498–6506
Contreras-García J, Johnson ER, Keinan S, Chaudret R, Piquemal J-P, Beratan DN, Yang W (2011) J Chem Theory Comput 7:625–632
Virnau P, Müller M (2004) J Chem Phys 120:10925–10930
Torrie GM, Valleau JP (1977) J Comput Phys 23:187–199
Acknowledgements
This work was funded by the Conselleria d’Educació, Cultura i Universitats (Ajuts a accions especials d’R+D AAEE044/2012 and AAEE027/2014). The authors are grateful to Sanifit Laboratoris S.L. for financial support for this research. One of us (D.F.) wishes to acknowledge the Spanish MEC for his Ph.D. grant (AP2010-6043) within the FPU program.
Author information
Authors and Affiliations
Corresponding author
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Fernández, D., Ramis, R., Ortega-Castro, J. et al. New insights into human farnesyl pyrophosphate synthase inhibition by second-generation bisphosphonate drugs. J Comput Aided Mol Des 31, 675–688 (2017). https://doi.org/10.1007/s10822-017-0034-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10822-017-0034-5